InvestorsObserver is giving Viela Bio Inc (VIE) an Analyst Rating Rank of 68, meaning VIE is ranked higher by analysts than 68% of stocks. The average projection by analysts for VIE is $64.6 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
Investors Observer takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Viela Bio Inc Stock Today?
Viela Bio Inc (VIE) stock is higher by 4.23% while the S&P 500 is down -0.16% as of 3:02 PM on Tuesday, Sep 29. VIE is higher by $1.12 from the previous closing price of $26.48 on volume of 104,318 shares. Over the past year the S&P 500 is higher by 14.97% while VIE is higher by 17.90%. VIE lost -$3.18 per share the over the last 12 months.
Click Here to get the full report on Viela Bio Inc (VIE) Stock.
